痰热清联合阿奇霉素治疗支原体肺炎的效果观察

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (43 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To eva1uate and ana1yze the c1inica1 effect of ranreqing combined with azithromycin in the treatment of Mycoplasma pneumonia，and optimize therapeutic regimen.Methods 124 patients with Mycoplasma pneumonia admitted into our hospita1 from January 2014 to January 2016 were screened.By a random number tab1e，they were even1y divided into treatment group and contro1 group.In the contro1 group，on the basis of re1ieving cough and abating fever，sequentia1 therapy of azithromycin was adopted.In the treatment group，on the basis of the contro1 group，tanreqing injection was added.The c1inica1 effect，serum C-reactive protein（CRP），tumor necrosis factor-α（TNF-α），inter1eukin-6 （IL-6），and disappearing time of 1ung ra1e，fever，cough，and shadow of chest X-ray were compared between the two groups.Results After therapy，the 1eve1 of IL-6，TNF-α，and CRP was decreased respective1y，and the decrease in the treatment group was more obvious than that in the contro1 group respective1y（P＜0.05）.Disappearing time of cough，fever，shadow of chest X-ray，and 1ung ra1e was shorter in the treatment group compared with that in the contro1 group respective1y（P＜0.05）.The tota1 effective rate in the treatment group was superior to that in the contro1 group and the incidence of adverse reaction was 1ower in the treatment group，which were disp1ayed statistica1 differences（Both P＜0.05）.Conclusion Tanreqing combined with azithromycin in the treatment of Mycoplasma pneumonia can obtain a remarkab1e effect.Its effect is better than that on1y by azithromycin at advantages of few adverse reactions，safety，and re1iabi1ity，which has a va1ue of promotion.

Key words： Azithromycin Tanreqing Mycoplasma pneumonia Adverse reaction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Li-xia
	TAN Yin-feng
	ZHANG Xiu-zhen

Cite this article:

CHEN Li-xia,TAN Yin-feng,ZHANG Xiu-zhen. Effect observation of tanreqing combined with azithromycin in the treatment of Mycoplasma Pneumonia[J]. 中国当代医药, 2016, 23(14): 121-123.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2016/V23/I14/121

［1］	许志有.阿奇霉素治疗支原体肺炎患儿临床疗效分析［J］.海南医学院学报，2012，18（2）：238-242.
［2］	滕宁燕.支原体肺炎患儿血清TNF-α、IL-6、IL-8的检测及其临床意义［J］.中华医院感染学杂志，2012，22（3）：533-535.
［3］	屠苗英.血清白细胞介素6、8水平在支原体肺炎患儿中的变化及意义［J］.中国基层医药，2011，18（14）：1928-1929.
［4］	许丹彦.痰热清联合阿奇霉素治疗小儿支原体肺炎对比分析［J］.中国慢性病预防与控制，2011，19（6）：631-632.
［5］	杜金华.阿奇霉素联合痰热清治疗小儿支原体肺炎的疗效［J］.中国实用医刊，2011，38（20）：96-97.
［6］	胡亚美，江载芳.诸福棠实用儿科学［M］.7版.北京：人民卫生出版社，2002：1204-1205.
［7］	王兆建.痰热清联合阿奇霉素治疗儿童支原体肺炎观察［J］.医学信息，2011，24（5）：2059-2060.
［8］	董晓艳，陆权.小儿肺炎支原体感染的诊治现状与进展［J］.实用儿科临床杂志，2011，26（4）：235.
［9］	江受传，虞坚尔.中医儿科学［M］.9版.北京：中国中医药出版社，2012：84-86.
［10］	羊礼荣.小儿肺炎支原体感染368例临床分析［J］.实用临床医药杂志，2011，15（17）：18-21.
［11］	刘继凯.阿奇霉素加舒利迭治疗儿童支原体肺炎疗效观察［J］.实用临床医药杂志，2010，14（9）：80-81.
［12］	韩秀峰.阿奇霉素治疗儿童支原体肺炎的临床观察［J］.中国药物与临床，2010，10（7）：802-803.
［13］	朱波，刘国群.阿奇霉素治疗小儿肺炎支原体肺炎的疗效和安全性探讨［J］.中国医药指南，2013，11（1）：137-138.
［14］	沈刚.新编实用儿科药物手册［M］.2版.北京：人民军医出版社，2010：137.
［15］	薛斌.痰热清注射液辅助治疗小儿肺炎支原体肺炎治疗效果分析［J］.吉林医学，2012，33（32）：7001-7002.